Cannabis
CBDCapitalGroup Welcomes Cannabis Industry Leader and Innovator Kimberly Kovacs to Company’s Advisory Council
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — CBDCapitalGroup (“CCG” or the “Company”), a CBD nutraceuticals investment and scaling company, today announced that respected cannabis industry leader and innovator Kimberly Kovacs has joined the Company’s Advisory Council.
Through her current and previous roles, Kovacs has earned a reputation in the technology and cannabis industries for her ability to identify companies with the ability to disrupt the status quo and guide them to success. She has been an active angel investor for over a decade and has raised more than $100 million in equity capital. Notably, Kovacs served as the founder and CEO of cannabis technology platform MyJane, which was acquired by Manifest 7 in 2019. Currently, Kovacs serves as CEO of The Arcview Group and Chairman of Arcview Capital, a prominent cannabis investment firm and FINRA registered broker dealer.
“Since the founding of CBDCapitalGroup, we have understood the power of diversity and adding intelligent, powerful women to our team. Kovacs embodies this to the fullest extent and has consistently led early and mid-stage companies to success,” said CBDCapitalGroup CEO David Metzler. “We are invested in growing companies in the cannabis, health and technology industries that are poised for growth and on a mission to do good. We are proud to add Kimberly to our team because she contributes the expertise we need to achieve further success and aligns with our values.”
Previously, Kovacs either founded or co-founded several technology and life sciences companies over the course of two decades. With successfully exiting her last SaaS company, OptionEase (Solium acquired in 2012 then Morgan Stanley in 2019), she became an active member of Golden Seeds, an angel investment group focused on women, diversity and inclusion, where she also became the Managing Director for their Southern California Chapter. Other notable achievements include being named the first female board member for the prestigious OCTANE organization in Southern California, Board Member and then President of the Los Angeles Venture Association and now the first female chairperson for a licensed broker dealer in the cannabis space.
“The hemp-derived CBD space continues to grow at an impressive rate and has proven that it is here to stay. CBDCapitalGroup’s unique business model is built to create a self-running machine that brings success to the full portfolio,” said Kovacs. “In addition to his impressive investment strategy, David Metzler is an amazing leader as CEO of CBDCapitalGroup and he shares many of the same passions as I do.”
About CBDCapitalGroup:
CBDCapitalGroup (“CCG” or the “Company”) is an investment and scaling company that acquires and develops mid-stage CBD and hemp nutraceutical companies to promote both financial and professional success. The Company is led by a group of seasoned entrepreneurs who have managed over $1 billion in combined revenue over their careers, and now apply their diverse business experiences to establish trust, quality standards and efficiencies in the CBD market. The Company provides CBD industry entrepreneurs a faster path to revenue growth and liquidity with capital, expert advice and operational resources needed to scale already profitable businesses.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE:
None of the parties involved, including CBDCapitalGroup and Medix CBD, sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Medix CBD does grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
PUBLIC RELATIONS CONTACT:
Kathryn Reinhardt
Account Supervisor, CMW Media
P: 858-283-4005
Attachment
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care